NSE: SUMICHEM · BSE: 542920 · ISIN INE258G01013
Sumitomo Chemical India Limited stock analysis
Sumitomo Chemical India Limited ranks #1140 in the TickerSutra evidence-ranked universe with a score of 56/100 and 95% data confidence. The latest captured fundamentals show ROCE of 23.5%, quarterly sales growth of 0.6% and quarterly profit growth of 9.3%.Monitor only
INVESTMENT EVIDENCE
What supports—and challenges—the thesis
Evidence in favour
- ROCE is 23.5%
- Low debt/equity of 0.02×
- Institutional ownership is rising
- CWIP indicates an active capacity pipeline
- No promoter shares are reported as pledged
Risks and constraints
- Valuation is above 40× earnings
Still unresolved: Related-party exposure · Broad media sentiment
FINANCIAL TRAJECTORY
Recent operating history
| Period | Revenue | Operating profit | Net profit | Operating margin |
|---|---|---|---|---|
| 2022 | ₹3,060cr | ₹603cr | ₹434cr | 20.0% |
| 2023 | ₹3,511cr | ₹668cr | ₹503cr | 19.0% |
| 2024 | ₹2,833cr | ₹474cr | ₹370cr | 17.0% |
| 2025 | ₹3,090cr | ₹623cr | ₹502cr | 20.0% |
| 2026 | ₹3,186cr | ₹666cr | ₹543cr | 21.0% |
| TTM | ₹3,192cr | ₹680cr | ₹580cr | 21.0% |
EXCHANGE EVENT TRIGGERS
Latest corporate disclosures
MANAGEMENT COMMENTARY
Signals from filed documents
The expiry of global patents continues to create opportunities for domestic manufacturers to expand their presence in both domestic and export markets. Com panies are also investing in capacity expansion, backward integration, and partnerships to enhance operational efficiency and reduce dependency on imports. There is a growing emphasis on developing sustainable and environment-friendly solutions, including biologic
The Company continues to enjoy the reputation of a consistent and reliable quality supplier. In the year under review, your Company continued to pursue initiatives to optimise utilisation of its manufacturing facilities, launch new products and install manufacturing capacities to supply new products in domestic and international markets. The Company continues to take initiatives for introducing new technical grade pr
Increasing demand for high-quality food, growing awareness of crop protection practices, and the adoption of advanced technologies are expected to support long-term industry growth. Segments such as fungicides, plant growth regulators, and specialty products are likely to witness sustained demand. The Company, with its strong product portfolio, robust pipeline, and focus on innovation and farmer engagement, is well-p
(iii) Capital investment on energy conservation equipments: ₹ 162.38 million (B) TECHNOLOGY ABSORPTION a) Major efforts made towards technology absorption: i. Backward integration for some of the existing molecules/intermediates to attain self-sufficiency and to remain competitive. Enhancement of batch size(s) for technical products to maximize capacity utilization.
Agrochemical prices, however, remained relatively stable throughout the year, which helped maintain affordability for farmers and supported input accessibility. The industry also witnessed relatively low pipeline inventory levels, influencing supply dynamics and pricing trends across the market. Despite the operational challenges arising from weather variability and subdued farmer sentiment in certain crop segments,
On business mix, domestic revenue grew by 4% year-on-year in both Q4 and the full year, with the domestic franchise demonstrating genuine resilience. Our branded formulation share in domestic sales improved to 81% in FY '26 from 79% in FY '25, reflecting the ongoing structural shift towards higher quality, higher margin revenue. Export revenues declined 7% in Q4 and 1% for the full year, primarily due to shipment dif
The stability achieved during the year has given us the confidence to look beyond short-term challenges and focus on the next phase of growth. With strong brands, a robust product pipeline, deeper farmer engagement, and expanding digital capabilities, we are well-positioned to accelerate innovation, strengthen market leadership, and create sustainable value for Indian agriculture. Having built a stable platform, we n
Generation of in-house non-GLP chemistry data for registration of products for domestic and international markets. Development of new formulations and scale-up technologies for commercial production and to enhance production capacity of liquid and solid formulations. Upgrading synthetic and analytical laboratories with modern scientific tools in order to cater to newer chemistries.
Om P ower Transmission Limited (Chairman) 2. of shares held in the Company as on 31 March 2026 387 shares Relationship with other Directors and KMPs None Number of Board Meeting(s) attended during the year 2025-26Did not hold position of director in 2025-26 Remuneration drawn in 2025-26 None Remuneration and other terms and conditions of appointment Remuneration: Entitled to receive sitting fees for attending meeting
On working capital, our net working capital stood at 103 days as of 31st March 2026 versus 89 days a year ago. The increase reflects two deliberate factors: A seasonal inventory buildup ahead Sumitomo Chemical India Limited May 28, 2026 Page 9 of 18 of kharif to ensure uninterrupted product availability in an environment of global supply chain volatility, and a reduction in payable days, reflecting the tighter credit
Agricultural Scenario in India in 2025-26 The agricultural season during FY 2025–26 presented a mixed outlook. While crop acreage remained largely stable across most regions, the season was significantly impacted by adverse weather conditions and regulatory challenges to biostimulant products. Excess and prolonged rainfall during the period from July to September, extending into October in certain regions, led to cro
• SCC is a consistent and reliable buyer, ensuring optimal capacity utilization of the Company’s manufacturing facilities. • The Company achieves competitive pricing and margin levels through these sales. Other transactions: Other transactions with SCC are not material in value and are conducted in the ordinary course of business and are supported by appropriate documentation.
HOW TO READ THIS PAGE
Evidence, freshness and limitations
What does the TickerSutra score mean?
The score ranks captured evidence across financial quality, growth, moat and margins, regulatory catalysts, governance, institutional trend and valuation comfort. It is a research-prioritization tool—not a buy recommendation or price target.
Which sources support this page?
Financial history, ownership and pledge data, NSE and BSE filings, annual reports and available earnings-call transcripts are combined here. Use the source trail and original exchange document before relying on a decision-critical fact.
Why can an item be unresolved?
Unresolved means the current captured source window did not provide enough evidence for that check. It does not establish that a risk or relationship is absent.
Maintained by TickerSutra Research · Snapshot updated 29 Sept 2026 · Read the methodology · Read the disclaimer
DIRECTOR & BUSINESS NETWORK
Loading corporate intelligence
Loading universe coverage and exchange-backed evidence…